| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/06/2002 | EP1058533B1 High moisture toothpaste |
| 02/06/2002 | EP0762888B1 Copolymer-1 improvements in compositions of copolymers |
| 02/06/2002 | CN1334816A Triazolo (4,5-D) pyrimidine compounds |
| 02/06/2002 | CN1334800A 3,4,5-trisubstd. aryl nitrone compounds and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334720A Cosmetic skin care compositions contg 4-chromanone |
| 02/05/2002 | US6344483 Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors |
| 02/05/2002 | CA2242373C Teas for the amelioration of the effects of alcoholic drinks and processes for the production thereof |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002007719A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/31/2002 | WO2002007672A2 A medicinal aerosol formulation |
| 01/31/2002 | WO2001064182A3 Improvements in or relating to the delivery of oral drugs |
| 01/31/2002 | WO2001062801A3 Humanized antibodies that sequester amyloid beta peptide |
| 01/31/2002 | US20020013662 Pharmacokinetic-based drug design tool and method |
| 01/31/2002 | US20020013358 Indole derivatives |
| 01/31/2002 | US20020013321 Used as ligands for opioid receptors, for therapy of neurological and gastrointestinal disorders |
| 01/31/2002 | US20020012706 Method of making granular pharmaceutical vehicle |
| 01/31/2002 | US20020012635 Comprises a first formulation stored adjacent a second formulation for simultaneous dispensing, wherein the pH of first formulation differs from pH of second formulation; cleaning |
| 01/31/2002 | US20020010968 Composition for dyeing keratin fibers with a cationic direct dye and a thickening |
| 01/31/2002 | US20020010966 Oxidation dyeing composition for keratin fibres and dyeing method using said composition |
| 01/31/2002 | CA2412392A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/30/2002 | EP1175906A1 Blood flow improvers and thrombosis preventives or remedies comprising glucosamine |
| 01/30/2002 | EP1175896A1 Cosmetic composition suitable for sensitive and reactive skin |
| 01/30/2002 | EP1175429A1 Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a |
| 01/30/2002 | EP1175428A1 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/30/2002 | EP0707580B1 Magnesium omeprazole |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/30/2002 | CN1333682A Storable active substance concentrate with formoterol |
| 01/30/2002 | CN1333679A Dispersible phospholipid stabilzed microparticles |
| 01/29/2002 | US6342523 3,4,5-trisubstituted aryl nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation |
| 01/29/2002 | US6342497 2″-deoxy hygromycin derivatives |
| 01/29/2002 | US6342476 Treating multiple sclerosis by administering a copolymer reacted with hydrobromic acid |
| 01/29/2002 | US6342209 Cosmetic compositions containing film forming polymers plasticized with esters and malic acid |
| 01/29/2002 | US6342078 Oxidation color dyes for hair with metaphenylenediamine couplers |
| 01/24/2002 | US20020010550 Pharmacokinetic-based drug design tool and method |
| 01/24/2002 | US20020010206 Treating cyclooxygenase-2 mediated disorders. |
| 01/24/2002 | US20020010106 Compositions comprising cyclodextrin |
| 01/24/2002 | US20020009509 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 01/24/2002 | US20020007522 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 01/23/2002 | EP1173210A1 Contraceptive compositions containing antiprogestinic and progestinic |
| 01/23/2002 | EP1173176A1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 01/23/2002 | EP0941103B1 Pharmaceutical composition for treatment of diabetes |
| 01/23/2002 | CN1332731A Substituted benzimidazoles and their prep. and use |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/22/2002 | US6340695 Rapid onset formulation |
| 01/22/2002 | US6340479 Stable, homogeneous, extract free or nearly free form secondary reaction products |
| 01/22/2002 | CA1341334C Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
| 01/17/2002 | WO2002004021A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | WO2002003998A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | WO2002003983A1 Fatty acid analogues for the treatment of cancer |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 01/17/2002 | US20020006443 Drug in a solubility-improved form with a concentration-enhancing polymer such as hydroxypropyl methyl cellulose acetate succinate; combination improves bioavailability relative to a control of just solubility improved form |
| 01/17/2002 | US20020004959 Mixture containing oxidoreductase enzyme |
| 01/17/2002 | CA2415498A1 Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/17/2002 | CA2415100A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/17/2002 | CA2414480A1 Fatty acid analogues for the treatment of cancer |
| 01/16/2002 | EP1172041A2 Compositions of plant carbohydrates as dietary supplements |
| 01/16/2002 | EP1171142A1 Inflammatory mediation obtained from atractylodes lancea |
| 01/16/2002 | EP1171138A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions |
| 01/16/2002 | EP1171095A1 Skin cleaning method for eliminating comedones and scales from parts of the skin subjected to the proliferation of (candida albicans) |
| 01/16/2002 | EP1171085A1 Oral care composition |
| 01/16/2002 | EP1171077A2 Hair care compositions |
| 01/16/2002 | EP0952839B1 Green ointment |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof |
| 01/16/2002 | CN1331680A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331594A Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331581A Pharmaceutical aerosol compsn. contg. HFA227 and HFA 137 |
| 01/16/2002 | CN1077792C Pyridylbisphosphonates for use as therapeutical agent |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002149A1 Rhodamine diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/10/2002 | WO2002002054A2 Methods and compositions for the diagnosis of schizophrenia |
| 01/10/2002 | US20020004520 Crystalline(-)-3r,4r-trans-7methoxy-2,2-dimethyl-3-phenyl-4-{4-[2- (pyrrolidin-1-yl)ethoxy]pheny 1}chromane, hydrogen malete |
| 01/10/2002 | US20020004047 DNA encoding a novel RG1 polypeptide |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2383697A1 Rhodamine diagnostic agent and diagnostic methods for detection of epithelial cancer |
| 01/09/2002 | EP1169044A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence |
| 01/09/2002 | EP1169029A1 Method of treating sleep apnoea |
| 01/09/2002 | EP1169027A1 Treatment of osteoarthritis |
| 01/09/2002 | EP1169014A1 Antiperspirant compositions |
| 01/09/2002 | CN1330552A Oral vaccine against diarrhea |
| 01/09/2002 | CN1330548A Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agents |
| 01/09/2002 | CN1330539A Compositions and methods for treatment of anorectal disorders |
| 01/09/2002 | CN1330538A Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor |
| 01/09/2002 | CN1330533A Striped dentifric |
| 01/08/2002 | US6337087 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
| 01/08/2002 | CA2294614C Omeprazole sodium salt |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/03/2002 | WO2002000661A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS |
| 01/03/2002 | US20020001569 A toothpaste formulation comprises a core of abrasive material such as precipitated calcium carbonate, which is coated with a fluorine compatibilizing hydrophobic coating containing fatty chain (sodium stearate); anticaries agent |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/02/2002 | EP1165716A1 Adhesives |
| 01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
| 01/02/2002 | EP1165553A1 C10 ester substituted taxanes as antitumor agents |
| 01/02/2002 | EP1165552A1 C7 carbonate substituted taxanes as antitumor agents |